Miransertib(ARQ 092)
Catalog No: 17021301
CAS Number: 1313883-00-9
Purity: 98%
ARQ 092是一种新型的口服生物可用性和选择性AKT通路抑制剂，在晚期实体肿瘤患者中表现出可管理的安全性。
For research use only. We do not sell to patients.
Chemical Information
| Name | Miransertib(ARQ 092) |
|---|---|
| Iupac Chemical Name | 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine |
| Synonyms | ARQ092; ARQ-092; ARQ 092; Miransertib |
| Molecular Formula | C27H25ClN6 |
| Molecular Weight | 468.98 |
| Smile | NC1(CCC1)C1=CC=C(C=C1)N1C(=NC=2C1=NC(=CC2)C2=CC=CC=C2)C=2C(=NC=CC2)N |
| InChiKey | HNFMVVHMKGFCMB-UHFFFAOYSA-N |
| InChi | InChI=1S/C27H24N6/c28-24-21(8-4-17-30-24)25-32-23-14-13-22(18-6-2-1-3-7-18)31-26(23)33(25)20-11-9-19(10-12-20)27(29)15-5-16-27/h1-4,6-14,17H,5,15-16,29H2,(H2,28,30) |
| CAS Number | 1313883-00-9 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | 固体结晶 |
|---|---|
| Purity | 98% |
| Storage | 短期可在0-4度保存，数天至数月；长期可在-20度保存三年。 |
| Solubility | 可溶于DMSO |
| Handling | |
| Shipping Condition | 可在常温下运输 |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
-cas-1313883-00-9.png)